These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Braun J; Loyal L; Frentsch M; Wendisch D; Georg P; Kurth F; Hippenstiel S; Dingeldey M; Kruse B; Fauchere F; Baysal E; Mangold M; Henze L; Lauster R; Mall MA; Beyer K; Röhmel J; Voigt S; Schmitz J; Miltenyi S; Demuth I; Müller MA; Hocke A; Witzenrath M; Suttorp N; Kern F; Reimer U; Wenschuh H; Drosten C; Corman VM; Giesecke-Thiel C; Sander LE; Thiel A Nature; 2020 Nov; 587(7833):270-274. PubMed ID: 32726801 [TBL] [Abstract][Full Text] [Related]
6. S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit. Nguyen-Contant P; Embong AK; Kanagaiah P; Chaves FA; Yang H; Branche AR; Topham DJ; Sangster MY mBio; 2020 Sep; 11(5):. PubMed ID: 32978311 [TBL] [Abstract][Full Text] [Related]
7. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome. Weiskopf D; Schmitz KS; Raadsen MP; Grifoni A; Okba NMA; Endeman H; van den Akker JPC; Molenkamp R; Koopmans MPG; van Gorp ECM; Haagmans BL; de Swart RL; Sette A; de Vries RD Sci Immunol; 2020 Jun; 5(48):. PubMed ID: 32591408 [TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2. Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372 [TBL] [Abstract][Full Text] [Related]
9. Cross-reactive and mono-reactive SARS-CoV-2 CD4+ T cells in prepandemic and COVID-19 convalescent individuals. Johansson AM; Malhotra U; Kim YG; Gomez R; Krist MP; Wald A; Koelle DM; Kwok WW PLoS Pathog; 2021 Dec; 17(12):e1010203. PubMed ID: 34965282 [TBL] [Abstract][Full Text] [Related]
10. Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome. Crooke SN; Ovsyannikova IG; Kennedy RB; Poland GA Sci Rep; 2020 Aug; 10(1):14179. PubMed ID: 32843695 [TBL] [Abstract][Full Text] [Related]
11. Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2. Lin L; Ting S; Yufei H; Wendong L; Yubo F; Jing Z Virus Res; 2020 Oct; 288():198082. PubMed ID: 32621841 [TBL] [Abstract][Full Text] [Related]
12. Immunoinformatics-guided design of an epitope-based vaccine against severe acute respiratory syndrome coronavirus 2 spike glycoprotein. Rakib A; Sami SA; Mimi NJ; Chowdhury MM; Eva TA; Nainu F; Paul A; Shahriar A; Tareq AM; Emon NU; Chakraborty S; Shil S; Mily SJ; Ben Hadda T; Almalki FA; Emran TB Comput Biol Med; 2020 Sep; 124():103967. PubMed ID: 32828069 [TBL] [Abstract][Full Text] [Related]
13. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Mateus J; Grifoni A; Tarke A; Sidney J; Ramirez SI; Dan JM; Burger ZC; Rawlings SA; Smith DM; Phillips E; Mallal S; Lammers M; Rubiro P; Quiambao L; Sutherland A; Yu ED; da Silva Antunes R; Greenbaum J; Frazier A; Markmann AJ; Premkumar L; de Silva A; Peters B; Crotty S; Sette A; Weiskopf D Science; 2020 Oct; 370(6512):89-94. PubMed ID: 32753554 [TBL] [Abstract][Full Text] [Related]
14. An Effective COVID-19 Vaccine Needs to Engage T Cells. Sauer K; Harris T Front Immunol; 2020; 11():581807. PubMed ID: 33117391 [No Abstract] [Full Text] [Related]
15. Limited Recognition of Highly Conserved Regions of SARS-CoV-2. Swaminathan S; Lineburg KE; Ambalathingal GR; Crooks P; Grant EJ; Mohan SV; Raju J; Panikkar A; Le Texier L; Tong ZWM; Chew KY; Neller MA; Short KR; Gowda H; Gras S; Khanna R; Smith C Microbiol Spectr; 2022 Feb; 10(1):e0278021. PubMed ID: 35196796 [TBL] [Abstract][Full Text] [Related]
16. Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes. Poran A; Harjanto D; Malloy M; Arieta CM; Rothenberg DA; Lenkala D; van Buuren MM; Addona TA; Rooney MS; Srinivasan L; Gaynor RB Genome Med; 2020 Aug; 12(1):70. PubMed ID: 32791978 [TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Le Bert N; Tan AT; Kunasegaran K; Tham CYL; Hafezi M; Chia A; Chng MHY; Lin M; Tan N; Linster M; Chia WN; Chen MI; Wang LF; Ooi EE; Kalimuddin S; Tambyah PA; Low JG; Tan YJ; Bertoletti A Nature; 2020 Aug; 584(7821):457-462. PubMed ID: 32668444 [TBL] [Abstract][Full Text] [Related]
19. Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity. Rydyznski Moderbacher C; Ramirez SI; Dan JM; Grifoni A; Hastie KM; Weiskopf D; Belanger S; Abbott RK; Kim C; Choi J; Kato Y; Crotty EG; Kim C; Rawlings SA; Mateus J; Tse LPV; Frazier A; Baric R; Peters B; Greenbaum J; Ollmann Saphire E; Smith DM; Sette A; Crotty S Cell; 2020 Nov; 183(4):996-1012.e19. PubMed ID: 33010815 [TBL] [Abstract][Full Text] [Related]
20. Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals. Ni L; Ye F; Cheng ML; Feng Y; Deng YQ; Zhao H; Wei P; Ge J; Gou M; Li X; Sun L; Cao T; Wang P; Zhou C; Zhang R; Liang P; Guo H; Wang X; Qin CF; Chen F; Dong C Immunity; 2020 Jun; 52(6):971-977.e3. PubMed ID: 32413330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]